# Comprehensive Review and Revision Roadmap: GenoFold

## Part 1: Reviewer Assessment

### Summary of the Work

The manuscript introduces GenoFold, an end-to-end framework for reconstructing 3D genome architecture from multi-modal inputs, including Hi-C contact matrices, next-generation sequencing (NGS) coverage, k-mer composition, and genomic metadata. The architecture utilizes a four-layer GATv2 graph attention network paired with a six-layer Transformer to capture both local and global chromosomal dependencies. The framework distinguishes itself by integrating per-bin uncertainty quantification (using Monte Carlo dropout and a learned variance head) and built-in explainability metrics (Integrated Gradients and attention weights) directly into the reconstruction pipeline.

### Strengths

* 
**Comprehensive Architecture:** The integration of multiple genomic modalities beyond traditional Hi-C data  is biologically sound and represents a forward-thinking approach to genome reconstruction.


* 
**Novel Algorithmic Fusion:** Combining local graph attention (GATv2) with global sequence context (Transformers) elegantly addresses the limitations of purely local graph models.


* 
**Built-in Uncertainty and Explainability:** Providing epistemic and aleatoric uncertainty estimates alongside predicted coordinates is a significant advancement over standard point-estimate tools. Deriving feature attribution directly from the model using Integrated Gradients adds strong interpretive value.


* 
**Software Engineering:** The conceptualization of a seamless, six-stage pipeline that avoids fragmented, multi-tool workflows is a highly practical contribution.



### Major Weaknesses

* 
**Lack of Training and Validation:** The most critical flaw of this submission is that the neural network is completely untrained. The manuscript explicitly states that weights are randomly initialized and that supervised training is deferred to future work. Evaluating an untrained deep learning model solely on its ability to run end-to-end without crashing does not demonstrate scientific validity or algorithmic efficacy.


* 
**Absence of Quantitative Benchmarking:** The manuscript lists 3DMax, HiC-GNN, and FLAMINGO as comparisons , but restricts this comparison to a table of design capabilities rather than performance metrics. Without testing against experimentally resolved structures or comparing accuracy metrics, the method's utility remains entirely theoretical.


* 
**Extremely Limited Evaluation Scope:** The experimental execution is confined to a window of 200 bins on chromosome 22 , which filters down to merely 39 valid bins. This scale is insufficient to demonstrate the framework's capacity to handle realistic, genome-wide dependencies or to validate the Transformer's quadratic computational scaling claims.


* 
**Incomplete Modality Implementation:** The metadata modality utilizes a placeholder value (0.9) for mappability. Drawing conclusions about feature group importance is inappropriate when the model is both untrained and relying on dummy data.



### Final Decision: Reject

While the architectural design and the problem formulation are excellent, this manuscript reads as a software architecture proposal rather than a completed scientific study. In its current state, it lacks the empirical foundation required for publication in a rigorous computational biology venue. A computational framework must demonstrate not just that it can process data, but that it processes data accurately. Because the network weights are randomly initialized, the output coordinates, confidence scores, and attention heatmaps hold no biological or predictive meaning.

---

## Part 2: Recommended Fixes & Resubmission Roadmap

### Phase 1: Train and Validate the Network (The Absolute Priority)

The most critical missing piece is that the model is making predictions with randomly initialized weights.

* 
**Supervised Training:** As noted in the future work section, you must optimize the network against experimentally resolved 3D structures or reliable surrogate models.


* 
**Orthogonal Validation:** Validate the predicted 3D coordinates using independent experimental data, such as DNA FISH (Fluorescence In Situ Hybridization) distances. If the model accurately predicts FISH distances that were not included in the Hi-C training set, the empirical validity is strongly established.


* 
**Confirm the Uncertainty Metrics:** Once trained, prove that the Monte Carlo dropout and variance heads are properly calibrated. Show that when the model reports low confidence, the actual coordinate error (compared to ground truth) is demonstrably higher.



### Phase 2: Implement Rigorous Quantitative Benchmarking

Reviewers need to see quantitative evidence of performance.

* 
**Head-to-Head Comparison:** Run 3DMax, HiC-GNN, and FLAMINGO on the same GM12878 dataset.


* 
**Standardized Metrics:** Compare GenoFold against these baselines using standard field measures, such as distance Spearman correlation and the reproducibility of known TAD boundaries.


* 
**Ablation Studies:** Since the paper claims that multi-modality (NGS, k-mer, metadata) is a core differentiator, run GenoFold with all modalities, and then without them (Hi-C only). Show the quantitative drop in performance when the extra modalities are removed, especially in sparse genomic regions.



### Phase 3: Scale the Evaluation and Complete the Data

A 39-bin evaluation is too small to prove the viability of the pipeline.

* 
**Expand the Scope:** Test the pipeline on at least one full chromosome or several large contiguous regions. The paper mentions that processing overlapping windows block-wise can solve the scaling bottleneck of the eigensolve; this must be implemented and the runtime and memory usage reported.


* 
**Swap Placeholders for Real Data:** Replace the 0.9 mappability placeholder  with an actual genome-wide mappability track. A multi-modal framework must use real inputs for all its modalities to demonstrate its value.


* 
**Cross-Cell-Line Generalization:** Evaluate the model on a different cell line to prove that the architecture generalizes and is not over-fitted to the GM12878 data.



Addressing these empirical gaps will transition the manuscript from a conceptual software framework to a validated, highly competitive scientific contribution.